MedPath
HSA Approval

HYDROCORTISON TABLET 10 mg

SIN07203P

HYDROCORTISON TABLET 10 mg

HYDROCORTISON TABLET 10 mg

October 12, 1992

ORION PHARMA (SG) PTE. LTD.

ORION PHARMA (SG) PTE. LTD.

Regulatory Information

HSA regulatory responsibility and product classification details

Regulatory Responsibility

RegistrantORION PHARMA (SG) PTE. LTD.
Licence HolderORION PHARMA (SG) PTE. LTD.

Product Classification

D
Drug Type
Therapeutic
F
Forensic Class
Prescription Only
HSA Singapore Classification

Formulation Information

TABLET

**Dosage and Administration** Adults: For substitution therapy 20–30 mg/day, of which generally approx. 2/3 in the morning and 1/3 early in the evening. If necessary, the morning dose can be taken in two portions. For other indications, 40–200 mg/day, in short-term use for special indications even higher doses. Children: Dosage in children is individualised. In adrenocortical insufficiency, 7.5–15 mg/m2/day divided into three equal doses (immediately in the morning, in the afternoon, and late in the evening). The morning dose can also be higher than the other doses. In congenital adrenal hyperplasia, generally 10 mg/m2/day divided into three doses. In hypopituitarism, 2.5 mg three times daily. For dosage in stress situations, See Special Warning/Precautions – _please refer to the Product Insert/Patient Information Leaflet published on HSA for the full drug information_.

ORAL

Medical Information

**Indications** Adrenocortical insufficiency (Addison's disease), diminution of anterior pituitary function (hypopituitarism), congenital adrenal hyperplasia. Conditions where systemic glucocorticoid therapy is indicated.

**Contraindications** Tuberculosis and other acute or chronic bacterial and viral infections without antibiotic or chemotherapeutic protection, hypersensitivity to any ingredient of the preparation.

C05AA01

hydrocortisone

Manufacturer Information

ORION PHARMA (SG) PTE. LTD.

ORION CORPORATION (ESPOO PLANT)

Orion Corporation (Turku Plant)

Orion Corporation (Salo Plant) (Primary and Secondary Packager)

Active Ingredients

HYDROCORTISONE

10.0 mg

Hydrocortisone

Documents

Package Inserts

HYDROCORTISON Tablet PI.pdf

Approved: June 14, 2021

Download

MedPath

Empowering clinical research with data-driven insights and AI-powered tools.

© 2025 MedPath, Inc. All rights reserved.

HYDROCORTISON TABLET 10 mg - HSA Approval | MedPath